Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Summary

The purpose of this study is to assess the safety and tolerability of AMG 139 following multiple intravenous (IV) or subcutaneous (SC) dose administration in healthy subjects and in subjects with mild to severe Crohn's disease (CD).

Timeline

Start

2011-02-28

Primary completion

2015-02-18

Completion

2015-02-18

Drugs

Indications